Ayurveda is a several millennia old Indian medical system. Data from experimental, epidemiological and clinical studies provide compelling evidence that several ayurvedic naturoceuticals not only provide prophylactic and therapeutic activity against several diseases, but may actually improve general health and promote longevity. These include herbs, oils, spices, plants, minerals and trace amounts of heavy metals. Although widely used in India, firm scientific evidence for their effectiveness has been lacking due to the small and often improperly done clinical trials. However more expansive and rigorous research is now being done, providing evidence based data on the effectiveness and safety of these natural products. In the United States, Ayurvedic medications are regulated as dietary supplements. The third part of this four part series reviews another seven popular ayurvedic supplements.
This section of the four part article looks at saffron, shatavari, shilajit, triphala, turmeric, tamarind and terminalia arjuna.
Enstilar is specifically indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older.
Cotellic is specifically indicated for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, in combination with vemurafenib.
Kanuma is specifically indicated for the treatment of patients with a diagnosis of Lysosomal Acid Lipase (LAL) deficiency.
Onzetra Xsail is specifically indicated for the acute treatment of migraine with or without aura in adults. It is supplied as a powder for intranasal administration, delivered with the Xsail breath-powered delivery device only.
Briviact is specifically indicated as adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy.
Taltz (ixekizumab) a humanized interleukin-17A antagonist specifically indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
